NightHawk Biosciences Inc (NHWK)

[dia76ca]

The letter accompanying the proxy has a couple of interesting sentences...

"Our findings suggest that HS-110 plays an integral role in tumor reduction and may enhance efficacy of checkpoint inhibitors in lung cancer patients, especially for those patients least likely to respond to checkpoint therapies. We are encouraged by the positive response and level of interest from within the industry."

"POSITVE RESPONSE AND LEVEL OF INTEREST" from within the industry. This is good. But just to prepare for all contingencies this is followed by considerable discussion,later in the proxy, of remedies for a hostile takeover!

Someone on another board suggested this latest cash raise might be part of regaining control of the Shattuck Lab spinoff...just as some of the previous cash raise went toward the Pelican merger. We know Shattuck Labs had "an international pharmaceutical company" take part in their latest private placement. I wonder which company this is? I wonder what their next move might be? A lot of questions!